News NexgenRx Inc.

Equities

NXG

CA65337X1042

Market Closed - Toronto S.E. Other stock markets 02:14:32 2024-06-03 pm EDT			5-day change	1st Jan Change
0.29 ^CAD	+1.75%		+1.75%	+31.82%

May. 17	NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 16	Charles Burns Tenders Resignation as Director of NexgenRx Inc	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16	CI
Charles Burns Tenders Resignation as Director of NexgenRx Inc	May. 16	CI
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 05	CI
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	Dec. 29	CI
No data in subsection	Dec. 27	FA
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024	Dec. 20	CI
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 23	CI
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Ex-dividend day	23-06-21	FA
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023	23-06-15	CI
NexgenRx's Q1 Profit Falls, Revenue Rises	23-05-19	MT
NexgenRx Inc. Appoints Dave Bennett as New Director	23-05-18	CI
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-18	CI
NexgenRx Swings to Loss in Q4	23-04-10	MT
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-06	CI
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Ex-dividend day	22-09-28	FA
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022	22-09-23	CI
NexgenRx Announced Q2 2022 Financial Results	22-08-19	MT
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NexgenRx Inc.

Equities

NXG

CA65337X1042

Summary

Filters